NCT05622890 2022-11-21A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian CancerHangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Phase 3 Unknown35 enrolled